153 related articles for article (PubMed ID: 29849787)
1. Monoclonal antibody 3H11 chimeric antigen receptors enhance T cell effector function and exhibit efficacy against gastric cancer.
Han H; Wang S; Hu Y; Li Z; Yang W; Lv Y; Wang L; Zhang L; Ji J
Oncol Lett; 2018 May; 15(5):6887-6894. PubMed ID: 29849787
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning of a tumor-associated antigen recognized by monoclonal antibody 3H11.
Chen D; Shou C
Biochem Biophys Res Commun; 2001 Jan; 280(1):99-103. PubMed ID: 11162484
[TBL] [Abstract][Full Text] [Related]
3. Cloning of 3H11 mAb variable region gene and expression of 3H11 human-mouse chimeric light Chain.
Li J; Wang Y; Li QX; Wang YM; Xu JJ; Dong ZW
World J Gastroenterol; 1998 Feb; 4(1):41-44. PubMed ID: 11819228
[TBL] [Abstract][Full Text] [Related]
4. Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering.
Han X; Cinay GE; Zhao Y; Guo Y; Zhang X; Wang P
Mol Ther; 2017 Nov; 25(11):2466-2476. PubMed ID: 28784559
[TBL] [Abstract][Full Text] [Related]
5. [Construction of a new anti-CD123 chimeric antigen receptor T cells and effect of anti-acute myeloid leukemia].
Wang ZZ; Lu Y; Xu YX; Xing HY; Tang KJ; Tian Z; Rao Q; Wang M; Xiong DS; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):192-197. PubMed ID: 32311887
[No Abstract] [Full Text] [Related]
6. [Construction and expression of ScFv from anti-human gastric cancer McAb 3H11].
Li J; Wang Y; Li Q
Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):85-7. PubMed ID: 10920950
[TBL] [Abstract][Full Text] [Related]
7. c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer.
Kang CH; Kim Y; Lee DY; Choi SU; Lee HK; Park CH
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830894
[TBL] [Abstract][Full Text] [Related]
8. Mesothelin is a target of chimeric antigen receptor T cells for treating gastric cancer.
Lv J; Zhao R; Wu D; Zheng D; Wu Z; Shi J; Wei X; Wu Q; Long Y; Lin S; Wang S; Wang Z; Li Y; Chen Y; He Q; Chen S; Yao H; Liu Z; Tang Z; Yao Y; Pei D; Liu P; Zhang X; Zhang Z; Cui S; Chen R; Li P
J Hematol Oncol; 2019 Feb; 12(1):18. PubMed ID: 30777106
[TBL] [Abstract][Full Text] [Related]
9. IL-13Rα2 humanized scFv-based CAR-T cells exhibit therapeutic activity against glioblastoma.
Xu C; Bai Y; An Z; Hu Y; Zhang C; Zhong X
Mol Ther Oncolytics; 2022 Mar; 24():443-451. PubMed ID: 35141400
[TBL] [Abstract][Full Text] [Related]
10. Influences of amino acid sequences in FR1 region on binding activity of the scFv and Fab of an antibody to human gastric cancer cells.
Li J; Wang Y; Wang Z; Dong Z
Immunol Lett; 2000 Mar; 71(3):157-65. PubMed ID: 10722867
[TBL] [Abstract][Full Text] [Related]
11. Nanobody-based CAR-T cells for cancer immunotherapy.
Safarzadeh Kozani P; Naseri A; Mirarefin SMJ; Salem F; Nikbakht M; Evazi Bakhshi S; Safarzadeh Kozani P
Biomark Res; 2022 Apr; 10(1):24. PubMed ID: 35468841
[TBL] [Abstract][Full Text] [Related]
12. Effect of VL and VH consensus sequence-specific primers on the binding and expression of a mini-molecule antibody directed towards human gastric cancer.
Li J; Wang Y; Wang Z; Dong Z
Chin Med Sci J; 2000 Sep; 15(3):133-9. PubMed ID: 12903769
[TBL] [Abstract][Full Text] [Related]
13. Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer.
Jiang H; Shi Z; Wang P; Wang C; Yang L; Du G; Zhang H; Shi B; Jia J; Li Q; Wang H; Li Z
J Natl Cancer Inst; 2019 Apr; 111(4):409-418. PubMed ID: 30203099
[TBL] [Abstract][Full Text] [Related]
14. [The antitumor effect of adriamycin conjugated with monoclonal antibody against gastric cancer in vitro and in vivo].
Zhang YT; Wang NQ; Li N; Liu T; Dong ZW
Yao Xue Xue Bao; 1992; 27(5):325-30. PubMed ID: 1442051
[TBL] [Abstract][Full Text] [Related]
15. 3H11, a unique cell surface molecule involved in the function of the CD45RA+ subset of CD4+ cells.
Hirose T; Kobata T; Nojima Y; Schlossman SF; Morimoto C
Int Immunol; 1994 Aug; 6(8):1133-42. PubMed ID: 7981142
[TBL] [Abstract][Full Text] [Related]
16. [The selective cytotoxicity of monoclonal antibody conjugated with mitomycin C on human gastric cancer cells].
Liang YY; Wang NQ; Li N; Cui JQ; Dong ZW
Yao Xue Xue Bao; 1989; 24(11):801-6. PubMed ID: 2618675
[TBL] [Abstract][Full Text] [Related]
17. [Molecular cloning of the tumor associated antigen recognized by monoclonal antibody 3H11].
Chen D; Ma H; Wu J
Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(3):154-7. PubMed ID: 11798867
[TBL] [Abstract][Full Text] [Related]
18. FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance.
Caratelli S; Sconocchia T; Arriga R; Coppola A; Lanzilli G; Lauro D; Venditti A; Del Principe MI; Buccisano F; Maurillo L; Ferrone S; Sconocchia G
Front Immunol; 2017; 8():457. PubMed ID: 28496440
[TBL] [Abstract][Full Text] [Related]
19. The novel anti-CD19 chimeric antigen receptors with humanized scFv (single-chain variable fragment) trigger leukemia cell killing.
Qian L; Li D; Ma L; He T; Qi F; Shen J; Lu XA
Cell Immunol; 2016; 304-305():49-54. PubMed ID: 26996927
[TBL] [Abstract][Full Text] [Related]
20. Blocking CD38-driven fratricide among T cells enables effective antitumor activity by CD38-specific chimeric antigen receptor T cells.
Gao Z; Tong C; Wang Y; Chen D; Wu Z; Han W
J Genet Genomics; 2019 Aug; 46(8):367-377. PubMed ID: 31466926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
